Development of an Application-Based Digital Navigator for Perioperative Breast Surgery Patients
2 other identifiers
observational
60
1 country
1
Brief Summary
The goal of this research study is to learn how accessible JEEVA is for patients during the perioperative period (the time after the pre-operative surgical appointment, and up to 30 days after surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 28, 2022
CompletedFirst Submitted
Initial submission to the registry
March 3, 2022
CompletedFirst Posted
Study publicly available on registry
March 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 7, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 7, 2025
CompletedOctober 14, 2025
October 1, 2025
3.6 years
March 3, 2022
October 10, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Measure ease of use, interface and satisfaction with the electronic delivery of materials through the mobile health (mHealth) App Usability Questionnaire (MAUQ)
through study completion, an average of 1 year
Study Arms (1)
an application-based digital navigator
JEEVA" is a new digital health navigator app. This app can be used on a mobile phone or tablet. JEEVA has all of the surgical teaching information from the traditional paper packet and also has additional resources like brief videos, checklists, and reference photos.
Interventions
An app can be used on a mobile phone or tablet.
Eligibility Criteria
Breast Surgery Patients
You may qualify if:
- Subjects eligible for this study include breast surgical patients 18 years of age and older evaluated at the Texas Medical Center campus in the Nellie B Connally breast center or in the Houston Area Locations (HALs).
- This includes patients undergoing excisional biopsy, segmental mastectomy, total mastectomy, skin-sparing mastectomy, nipple-sparing mastectomy, sentinel lymphadenectomy, targeted axillary lymphadenectomy, axillary lymphadenectomy, and axillary reverse mapping.
You may not qualify if:
- Patients who do not have a smartphone), which utilizes iOS or Android operating systems,
- Patients who have visual impairment or blindness, which precludes effective utilization of an app, will be excluded.
- Patients whose surgical planning is discussed by telephone outside of an in-person pre-operative visit, will be excluded from the study.
- Patients who have cognitive impairment will be exclude
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
MD Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Christina Checka, MD
M.D. Anderson Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 3, 2022
First Posted
March 22, 2022
Study Start
February 28, 2022
Primary Completion
October 7, 2025
Study Completion
October 7, 2025
Last Updated
October 14, 2025
Record last verified: 2025-10